Feature | February 27, 2013

Oncology Information Systems' Reporting and Alerts Leave Providers Wanting More

As meaningful use and ACOs pick up steam, oncology providers contend with regulatory pressures with or without help from their vendors

Oncology Information Management Systems KLAS Meaningful Use Reports Alert

February 27, 2013 — Alerts and reporting are two of the most challenging aspects of medical oncology, in addition to being the tools providers are least happy with overall. This is according to a new report from KLAS titled Oncology 2012: Pulling the Curtain Back.

Study findings reveal that oncology information system vendors struggle with alerts. Specifically, Epic, Varian and Elekta seem to perform below average. Reporting is also an area for improvement. Providers report that Varian and Elekta's canned reports are not robust enough to meet their needs, and the customized reports are difficult to use. Epic's customized reports are not as user friendly as providers would like them to be.

Meaningful use (MU) is another hot button for providers. The vast majority of oncology providers interviewed indicate that they are planning to attest for MU, but according to the report, vendors differ in their ability to partner with providers in that effort. Altos and BMSi are the best reported MU partners because they are more hands on and appear to be more focused on customer needs.

Though Varian is one of the dominant players in the oncology IT market, the report indicates that they are not the best MU partner. The MU version of Varian ARIA did not come out on the promised timeline, and some providers report that Varian seems out of touch with customers. Additionally, Epic is identified as a vendor that could improve due to the fact that the system is not designed for all the needs of oncology providers.

With MU Stage 2 bearing down, patient portals are also identified as an important consideration for oncology providers. Only 30 percent of those surveyed said they are currently using a patient portal, and many still need to make that decision.

"Most of the Epic and Altos customers in the study said they are using patient portals; however, we spoke with only a small number of those customers," said Monique Rasband, oncology research director and author of the report. "The majority of Elekta and Varian customers have not yet adopted a portal. Most Varian and Elekta customers said they are looking to their current oncology IT vendor to supply a portal, in spite of most portals being rudimentary at this point."

This study includes ratings on medical and radiation oncology IS vendors. Vendors rated in radiation oncology are BMSi, Elekta and Varian. Vendors rated in medical oncology are Altos (early data), Elekta, Epic, IntrinsiQ and Varian. To learn more about the oncology IS market and the vendors in this study, providers and vendors can review the full report Oncology IT: Pulling the Curtain Back. This report is available to healthcare providers at a significant discount.

For more information: www.KLASresearch.com/KLASreports

Related Content

IBA, Klinikum Bayreuth Germany, first clinical application, Dolphin Transmission Detector, quality assurance, radiation therapy
News | Radiation Therapy | August 23, 2016
IBA (Ion Beam Applications S.A.) announced the first worldwide clinical implementation of its newly released Dolphin...
Agfa Healthcare, DIN-PACS IV agreement, U.S. government contract, diagnostic imaging, IT solutions
News | Business | August 23, 2016
Agfa HealthCare announced that the U.S. government has awarded the company its DIN-PACS IV (Digital Imaging Network/...
News | Radiation Therapy | August 19, 2016
August 19, 2016 — Early-stage breast cancer patients receiving a shorter course of...
Hitachi, proton beam therapy, PBT system, National Cancer Centre Singapore, NCCS, first in Southeast Asia
News | Proton Therapy | August 18, 2016
August 18, 2016 — Hitachi Asia Ltd. and Hitachi Ltd.
HIE, health information exchanges, participation strategy, Binghamton University
News | Information Technology | August 18, 2016
The U.S. healthcare industry has failed to create and sustain an efficient network for storing and sharing patient...
ProteusONE, IBA, FDA approval, FDA clearance of ProteusONE, compact proton therapy
Technology | Proton Therapy | August 18, 2016
August 18, 2016 — IBA (Ion Beam Applications SA) has received U.S.
Sponsored Content | Videos | Enterprise Imaging | August 16, 2016
Interview with Jef Williams, managing partner, Paragon Consulting Partners, on the essential elements of building an
high-risk prostate cancer, radical local treatment, Umea University Sweden study, mortality
News | Prostate Cancer | August 16, 2016
High-risk prostate cancer patients treated at hospitals with a high proportion of administered radical local treatment...
Sponsored Content | Videos | Analytics Software | August 16, 2016
Interview with Kent Hutson, M.D., CPE, of Radiology Alliance in Nashville, Tenn., on the principles of data mining an
Sponsored Content | Videos | Quality Assurance (QA) | August 15, 2016
Patient QA Efficiency with Dolphin presented at AAPM 2016 IBA booth.
Overlay Init